157 related articles for article (PubMed ID: 10528223)
1. Gene therapy using SV40-derived vectors: what does the future hold?
Strayer DS
J Cell Physiol; 1999 Dec; 181(3):375-84. PubMed ID: 10528223
[TBL] [Abstract][Full Text] [Related]
2. SV40-based gene therapy vectors: turning an adversary into a friend.
Strayer DS
Curr Opin Mol Ther; 2000 Oct; 2(5):570-8. PubMed ID: 11249759
[TBL] [Abstract][Full Text] [Related]
3. What can SV40-derived vectors do for gene therapy?
Strayer DS; Zern MA; Chowdhury JR
Curr Opin Mol Ther; 2002 Aug; 4(4):313-23. PubMed ID: 12222869
[TBL] [Abstract][Full Text] [Related]
4. Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors.
Strayer DS; Pomerantz RJ; Yu M; Rosenzweig M; BouHamdan M; Yurasov S; Johnson RP; Goldstein H
Gene Ther; 2000 May; 7(10):886-95. PubMed ID: 10845727
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing the production of recombinant SV40 vectors.
Vera M; Prieto J; Strayer DS; Fortes P
Mol Ther; 2004 Oct; 10(4):780-91. PubMed ID: 15451462
[TBL] [Abstract][Full Text] [Related]
6. Simian virus-40 as a gene therapy vector.
Vera M; Fortes P
DNA Cell Biol; 2004 May; 23(5):271-82. PubMed ID: 15169607
[TBL] [Abstract][Full Text] [Related]
7. SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.
Jayan GC; Cordelier P; Patel C; BouHamdan M; Johnson RP; Lisziewicz J; Pomerantz RJ; Strayer DS
Gene Ther; 2001 Jul; 8(13):1033-42. PubMed ID: 11438838
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selection.
BouHamdan M; Duan LX; Pomerantz RJ; Strayer DS
Gene Ther; 1999 Apr; 6(4):660-6. PubMed ID: 10476226
[TBL] [Abstract][Full Text] [Related]
9. Replication-deficient rSV40 mediate pancreatic gene transfer and long-term inhibition of tumor growth.
Cordelier P; Bienvenu C; Lulka H; Marrache F; Bouisson M; Openheim A; Strayer DS; Vaysse N; Pradayrol L; Buscail L
Cancer Gene Ther; 2007 Jan; 14(1):19-29. PubMed ID: 16990845
[TBL] [Abstract][Full Text] [Related]
10. SV40 vectors carrying minimal sequence of viral origin with exchangeable capsids.
Nakanishi A; Chapellier B; Maekawa N; Hiramoto M; Kuge T; Takahashi RU; Handa H; Imai T
Virology; 2008 Sep; 379(1):110-7. PubMed ID: 18667220
[TBL] [Abstract][Full Text] [Related]
11. Titering replication-defective rSV40 vectors.
Strayer DS; Mitchell C; Maier DA; Nichols CN
Cold Spring Harb Protoc; 2010 Jun; 2010(6):pdb.prot5437. PubMed ID: 20516175
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus enhances transduction of human hepatocytes by SV40-based vectors.
Arad U; Axelrod J; Ben-nun-Shaul O; Oppenheim A; Galun E
J Hepatol; 2004 Mar; 40(3):520-6. PubMed ID: 15123369
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer using recombinant simian virus 40 viral vectors into mice bone marrow progenitor cells depressed the immunogenicity of keratinocyte stem cells.
Li W; Xu T; Wang JF; Wu XF; Li M; Lu PY
Transplant Proc; 2008 Dec; 40(10):3656-9. PubMed ID: 19100460
[TBL] [Abstract][Full Text] [Related]
14. Gene delivery to the liver using simian virus 40-derived vectors.
Strayer DS; Zern MA
Semin Liver Dis; 1999; 19(1):71-81. PubMed ID: 10349685
[TBL] [Abstract][Full Text] [Related]
15. Strategies for CNS-directed gene delivery: in vivo gene transfer to the brain using SV40-derived vectors.
Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele E; Strayer DS
Gene Ther; 2007 Jun; 14(12):939-49. PubMed ID: 17443215
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis.
Agrawal L; Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
Gene Ther; 2006 Dec; 13(23):1645-56. PubMed ID: 16871233
[TBL] [Abstract][Full Text] [Related]
17. Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells.
Strayer DS; Kondo R; Milano J; Duan LX
Gene Ther; 1997 Mar; 4(3):219-25. PubMed ID: 9135735
[TBL] [Abstract][Full Text] [Related]
18. Production of SV40-derived vectors.
Strayer DS; Mitchell C; Maier DA; Nichols CN
Cold Spring Harb Protoc; 2010 Jun; 2010(6):pdb.prot5436. PubMed ID: 20516174
[TBL] [Abstract][Full Text] [Related]
19. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
[TBL] [Abstract][Full Text] [Related]
20. Retroviral vectors for gene therapy of AIDS and cancer.
Chang LJ; He J
Curr Opin Mol Ther; 2001 Oct; 3(5):468-75. PubMed ID: 11699891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
